As of 2026-03-24, the Relative Valuation of Homology Medicines Inc (FIXX) is (1,717.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.55 USD, the upside of Homology Medicines Inc based on Relative Valuation is -7096.2%.
The range of the Relative Valuation is (1,558.96) - (1,815.11) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.4x - 22.7x | 20.0x |
| Forward P/E multiples | 17.6x - 21.4x | 20.5x |
| Fair Price | (1,558.96) - (1,815.11) | (1,717.57) |
| Upside | -6450.1% - -7493.5% | -7096.2% |
| Date | P/E |